Advertisement
Research ArticleNEUROPHARMACOLOGY

Levetiracetam Potentiates the Antidyskinetic Action of Amantadine in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson's Disease

Michael P. Hill, Paula Ravenscroft, Erwan Bezard, Alan R. Crossman, Jonathan M. Brotchie, Anne Michel, Renee Grimée and Henrik Klitgaard
Journal of Pharmacology and Experimental Therapeutics July 2004, 310 (1) 386-394; DOI: https://doi.org/10.1124/jpet.104.066191

Article Information

vol. 310 no. 1 386-394
DOI 
https://doi.org/10.1124/jpet.104.066191
PubMed 
15004218
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received January 27, 2004
  • Accepted March 5, 2004
  • Published online June 17, 2004.

Article Versions

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Michael P. Hill,
  2. Paula Ravenscroft,
  3. Erwan Bezard,
  4. Alan R. Crossman,
  5. Jonathan M. Brotchie,
  6. Anne Michel,
  7. Renee Grimée and
  8. Henrik Klitgaard
  1. Motac Neuroscience Ltd, Manchester, United Kingdom (M.P.H., P.R., A.R.C.); Basal Gang, Laboratoire de Neurophysiologie, Universite Victor Segalen-Bordeaux 2, Bordeaux, France (E.B.); University of Manchester, School of Biological Sciences, Manchester, United Kingdom (A.R.C.); Toronto Western Research Institute, Toronto Western Hospital, Toronto, Canada (J.M.B.); and UCB S.A., Pharma Sector, Preclinical CNS Research, Braine L'Alleud, Belgium (A.M., R.G., H.K.)
  1. Address correspondence to:
    Henrik Klitgaard, UCB S.A. Pharma Sector, Preclinical CNS Research, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium. E-mail: henrik.klitgaard{at}ucb-group.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: March 2004 to November 2023

AbstractFullPdf
Mar 200468071
Apr 200424047
May 200422032
Jun 20041225991
Jul 20041187856
Aug 2004975427
Sep 2004473917
Oct 2004533417
Nov 2004724419
Dec 200445238
Jan 200541208
Feb 200532247
Mar 200527199
Apr 200516217
May 200511247
Jun 200534416
Jul 2005153611
Aug 2005142824
Sep 200582216
Oct 2005171512
Nov 2005133311
Dec 200552710
Jan 2006202914
Feb 2006221721
Mar 200662914
Apr 200651313
May 20069208
Jun 200672313
Jul 200661611
Aug 20069116
Sep 2006152318
Oct 2006251816
Nov 2006111612
Dec 200641614
Jan 2007251515
Feb 2007152125
Mar 2007212328
Apr 2007151511
May 2007111814
Jun 2007131112
Jul 2007162214
Aug 200791213
Sep 2007171015
Oct 2007171927
Nov 200771217
Dec 2007799
Jan 200861317
Feb 200842312
Mar 200812911
Apr 2008211614
May 2008141410
Jun 2008322014
Jul 2008222835
Aug 2008102113
Sep 2008637
Oct 2008111710
Nov 2008141214
Dec 2008685
Jan 2009101110
Feb 20091476
Mar 200911714
Apr 2009151211
May 2009121512
Jun 20091057
Jul 2009161510
Aug 200914813
Sep 20091689
Oct 200912129
Nov 200991010
Dec 20091356
Jan 2010221011
Feb 2010151120
Mar 201091211
Apr 201011159
May 2010151013
Jun 2010171010
Jul 20101083
Aug 20101237
Sep 20106617
Oct 201013616
Nov 2010111315
Dec 20109812
Jan 201181212
Feb 2011101017
Mar 2011111212
Apr 20119611
May 201181013
Jun 20118920
Jul 201115616
Aug 2011191915
Sep 201120813
Oct 2011131913
Nov 2011282014
Dec 20111089
Jan 2012181315
Feb 2012141315
Mar 201224919
Apr 20122397
May 2012161614
Jun 201215714
Jul 2012162115
Aug 201271413
Sep 20126914
Oct 201213616
Nov 2012131012
Dec 20129610
Jan 2013101114
Feb 20133488
Mar 2013141519
Apr 201319720
May 2013121013
Jun 20137104
Jul 20133714
Aug 2013909
Sep 2013877
Oct 20131492
Nov 20137211
Dec 20139105
Jan 20141147
Feb 20141412
Mar 2014967
Apr 201415107
May 2014658
Jun 201415158
Jul 201419133
Aug 2014668
Sep 20143119
Oct 2014749
Nov 20141116
Dec 201410610
Jan 2015557
Feb 20156610
Mar 2015723
Apr 20151140
May 20151056
Jun 20151154
Jul 20158109
Aug 20157105
Sep 2015959
Oct 20151242
Nov 20151549
Dec 20151357
Jan 20161316
Feb 2016656
Mar 201618912
Apr 20161239
May 201610511
Jun 201611614
Jul 20166412
Aug 201681011
Sep 2016748
Oct 201602417
Nov 20167166
Dec 20160129
Jan 20175167
Feb 201721647
Mar 2017323211
Apr 201701988
May 2017523411
Jun 2017419913
Jul 2017411815
Aug 201712611
Sep 201721413
Oct 201721818
Nov 20172139
Dec 2017394
Jan 20187129
Feb 20181166
Mar 201841610
Apr 201821410
May 20183188
Jun 201831610
Jul 201882421
Aug 20184149
Sep 20181816
Oct 20181914
Nov 201811012
Dec 20181227
Jan 20191035
Feb 2019800
Mar 20195105
Apr 2019601
May 2019422
Jun 20191307
Jul 20191023
Aug 20191702
Sep 20192404
Oct 20192563
Nov 20193123
Dec 20192103
Jan 20201523
Feb 20201000
Mar 2020700
Apr 20202233
May 2020712
Jun 2020320
Jul 2020700
Aug 2020204
Sep 2020810
Oct 2020403
Nov 2020503
Dec 20202230
Jan 20211723
Feb 20212775
Mar 20212175
Apr 20211223
May 20211852
Jun 20212431
Jul 20212611
Aug 20211743
Sep 20211122
Oct 20211215
Nov 20213128
Dec 20211327
Jan 20221724
Feb 20221656
Mar 20221212
Apr 20222417
May 2022511
Jun 2022921
Jul 20223312
Aug 20221112
Sep 20222639
Oct 20221603
Nov 2022912
Dec 2022921
Jan 202322810
Feb 2023821
Mar 20232226
Apr 2023726
May 20231712
Jun 20231744
Jul 20232604
Aug 20231324
Sep 2023410
Oct 20231627
Nov 2023965

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleNEUROPHARMACOLOGY

Levetiracetam Potentiates the Antidyskinetic Action of Amantadine in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson's Disease

Michael P. Hill, Paula Ravenscroft, Erwan Bezard, Alan R. Crossman, Jonathan M. Brotchie, Anne Michel, Renee Grimée and Henrik Klitgaard
Journal of Pharmacology and Experimental Therapeutics July 1, 2004, 310 (1) 386-394; DOI: https://doi.org/10.1124/jpet.104.066191
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement